Skip to main content
Top
Published in: Gastric Cancer 1/2015

01-01-2015 | Original Article

Laparoscopic completion total gastrectomy for remnant gastric cancer: a single-institution experience

Authors: Sang-Yong Son, Chang Min Lee, Do-Hyun Jung, Ju-Hee Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim

Published in: Gastric Cancer | Issue 1/2015

Login to get access

Abstract

Background

The aim of the present study was to evaluate the feasibility of laparoscopic completion total gastrectomy (LCTG) in patients with remnant gastric cancer.

Methods

Patients who underwent completion total gastrectomy for remnant gastric cancer between May 2003 and December 2012 were divided into two groups: an open completion total gastrectomy (OCTG) group and an LCTG group. Clinicopathological data, operative data, and patient survival rates were analyzed.

Results

Thirty-four remnant gastrectomies (17 OCTG and 17 LCTG) were performed. The mean time interval between the prior gastrectomy and the remnant gastrectomy was 17.2 years, and benign disease showed a longer time interval than malignancy (30.9 vs. 8.1 years; p < 0.0001). LCTG required a longer operation time than OCTG (234.4 vs. 170.0 min; p = 0.002); however, there were no significant differences in the estimated blood loss, the number of retrieved lymph nodes, the time to first flatus passage, the length of hospital stay, complication rates, and postoperative analgesia between the two groups. Eight patients (47.1 %) required conversion to open surgery during LCTG. The median overall survival was 69.1 months. There was no difference in 5-year survival between the two groups (p = 0.085).

Conclusion

LCTG was technically feasible; however, it showed no definitive clinical advantage over OCTG.
Literature
1.
go back to reference Sinning C, Schaefer N, Standop J, Hirner A, Wolff M. Gastric stump carcinoma—epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007;33:133–9.PubMedCrossRef Sinning C, Schaefer N, Standop J, Hirner A, Wolff M. Gastric stump carcinoma—epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007;33:133–9.PubMedCrossRef
2.
go back to reference Tanigawa N, Nomura E, Niki M, Shinohara H, Nishiguchi K, Okuzawa M, et al. Clinical study to identify specific characteristics of cancer newly developed in the remnant stomach. Gastric Cancer. 2002;5:23–8.PubMedCrossRef Tanigawa N, Nomura E, Niki M, Shinohara H, Nishiguchi K, Okuzawa M, et al. Clinical study to identify specific characteristics of cancer newly developed in the remnant stomach. Gastric Cancer. 2002;5:23–8.PubMedCrossRef
3.
go back to reference Lundegardh G, Adami HO, Helmick C, Zack M, Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med. 1998;319:195–200.CrossRef Lundegardh G, Adami HO, Helmick C, Zack M, Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med. 1998;319:195–200.CrossRef
4.
go back to reference Arnthorsson G, Tulinius H, Egilsson V, Sigvaldason H, Magnusson B, Thorarinsson H. Gastric cancer after gastrectomy. Int J Cancer. 1998;42:365–7.CrossRef Arnthorsson G, Tulinius H, Egilsson V, Sigvaldason H, Magnusson B, Thorarinsson H. Gastric cancer after gastrectomy. Int J Cancer. 1998;42:365–7.CrossRef
5.
go back to reference Caygill CP, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986;1:929–31.PubMedCrossRef Caygill CP, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986;1:929–31.PubMedCrossRef
6.
go back to reference Tersmette AC, Offerhaus GJ, Tersmette KW, Giardiello FM, Moore GW, Tytgat GN, et al. Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res. 1990;50:6486–9.PubMed Tersmette AC, Offerhaus GJ, Tersmette KW, Giardiello FM, Moore GW, Tytgat GN, et al. Meta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res. 1990;50:6486–9.PubMed
8.
go back to reference Lee SI, Choi YS, Park DJ, Kim HH, Yang HK, Kim MC. Comparative study of laparoscopy-assisted distal gastrectomy and open distal gastrectomy. J Am Coll Surg. 2006;202:874–80.PubMedCrossRef Lee SI, Choi YS, Park DJ, Kim HH, Yang HK, Kim MC. Comparative study of laparoscopy-assisted distal gastrectomy and open distal gastrectomy. J Am Coll Surg. 2006;202:874–80.PubMedCrossRef
9.
go back to reference Hwang SH, Park DJ, Jee YS, Kim MC, Kim HH, Lee HJ, et al. Actual 3-year survival after laparoscopy-assisted gastrectomy for gastric cancer. Arch Surg. 2009;144:559–64.PubMedCrossRef Hwang SH, Park DJ, Jee YS, Kim MC, Kim HH, Lee HJ, et al. Actual 3-year survival after laparoscopy-assisted gastrectomy for gastric cancer. Arch Surg. 2009;144:559–64.PubMedCrossRef
10.
go back to reference Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010;251:417–20.PubMedCrossRef Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010;251:417–20.PubMedCrossRef
11.
go back to reference Lee JH, Park do J, Kim HH, Lee HJ, Yang HK. Comparison of complications after laparoscopy-assisted distal gastrectomy and open distal gastrectomy for gastric cancer using the Clavien–Dindo classification. Surg Endosc. 2012;26:1287–95.PubMedCrossRef Lee JH, Park do J, Kim HH, Lee HJ, Yang HK. Comparison of complications after laparoscopy-assisted distal gastrectomy and open distal gastrectomy for gastric cancer using the Clavien–Dindo classification. Surg Endosc. 2012;26:1287–95.PubMedCrossRef
12.
go back to reference Lee JH, Son SY, Lee CM, Ahn SH, Park DJ, Kim HH. Morbidity and mortality after laparoscopic gastrectomy for advanced gastric cancer: results of a phase II clinical trial. Surg Endosc. 2013;27:2877–85.PubMedCrossRef Lee JH, Son SY, Lee CM, Ahn SH, Park DJ, Kim HH. Morbidity and mortality after laparoscopic gastrectomy for advanced gastric cancer: results of a phase II clinical trial. Surg Endosc. 2013;27:2877–85.PubMedCrossRef
13.
go back to reference Son SY, Lee CM, Lee JH, Ahn SH, Kim JW, Lee KU, et al. Laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for advanced gastric cancer with isolated para-aortic lymph node metastasis. J Korean Surg Soc. 2013;84:304–8.PubMedCentralPubMedCrossRef Son SY, Lee CM, Lee JH, Ahn SH, Kim JW, Lee KU, et al. Laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for advanced gastric cancer with isolated para-aortic lymph node metastasis. J Korean Surg Soc. 2013;84:304–8.PubMedCentralPubMedCrossRef
14.
go back to reference Lee JH, Ahn SH, Park do J, Kim HH, Lee HJ, Yang HK. Laparoscopic total gastrectomy with D2 lymphadenectomy for advanced gastric cancer. World J Surg. 2012;36:2394–9.PubMedCrossRef Lee JH, Ahn SH, Park do J, Kim HH, Lee HJ, Yang HK. Laparoscopic total gastrectomy with D2 lymphadenectomy for advanced gastric cancer. World J Surg. 2012;36:2394–9.PubMedCrossRef
15.
go back to reference Yamada H, Kojima K, Yamashita T, Kawano T, Sugihara K, Nihei Z. Laparoscopy-assisted resection of gastric remnant cancer. Surg Laparosc Endosc Percutan Tech. 2005;15:226–9.PubMedCrossRef Yamada H, Kojima K, Yamashita T, Kawano T, Sugihara K, Nihei Z. Laparoscopy-assisted resection of gastric remnant cancer. Surg Laparosc Endosc Percutan Tech. 2005;15:226–9.PubMedCrossRef
16.
go back to reference Park JH, Lee YJ, Jeong CY, Ju YT, Jung EJ, Hong SC. The laparoscopic approach for gastric remnant cancer. J Korean Surg Soc. 2008;74:418–23. Park JH, Lee YJ, Jeong CY, Ju YT, Jung EJ, Hong SC. The laparoscopic approach for gastric remnant cancer. J Korean Surg Soc. 2008;74:418–23.
17.
go back to reference Shinohara T, Hanyu N, Tanaka Y, Murakami K, Watanabe A, Yanaga K. Totally laparoscopic complete resection of the remnant stomach for gastric cancer. Langenbecks Arch Surg. 2013;398:341–5.PubMedCrossRef Shinohara T, Hanyu N, Tanaka Y, Murakami K, Watanabe A, Yanaga K. Totally laparoscopic complete resection of the remnant stomach for gastric cancer. Langenbecks Arch Surg. 2013;398:341–5.PubMedCrossRef
18.
go back to reference Japanese Gastric Cancer A. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.CrossRef Japanese Gastric Cancer A. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.CrossRef
Metadata
Title
Laparoscopic completion total gastrectomy for remnant gastric cancer: a single-institution experience
Authors
Sang-Yong Son
Chang Min Lee
Do-Hyun Jung
Ju-Hee Lee
Sang-Hoon Ahn
Do Joong Park
Hyung-Ho Kim
Publication date
01-01-2015
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2015
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-014-0339-1

Other articles of this Issue 1/2015

Gastric Cancer 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine